We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00123942
Recruitment Status : Terminated (After review of safety events and have decided that further dose escalation of MEDI-507 as a single agent is not feasible.)
First Posted : July 26, 2005
Last Update Posted : June 14, 2007
Sponsor:
Information provided by:

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : No date given